Artificial intelligence healthcare technology company Medopad has just landed $28 million in a Series A funding round with lead investments from China’s NWS Holdings. But the company announced that its goal is to raise $120 million in the next few months.
This funding comes after Medopad struck a series of 15 trade deals with Chinese firms, collectively worth more than $140 million (100 million...